Drugs / TIFENAZOXIDE
TIFENAZOXIDE
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04744129 Comparator | Feb 2022 → Feb 2023 | migraine disorder | Danish Headache Center | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIFENAZOXIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL135191 ↗ |
| Known as | NN414 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04744129 ↗ |
| Known as | Tifenazoxido | ChEMBL registry synonym — accepted as the source's own label CHEMBL135191 ↗ |
| Action | Activate | “selective KATP channel opener” PMID 38729773 ↗ May 2024 |
| Modality | Small molecule | — CHEMBL135191 ↗ |